Literature DB >> 33551298

Statins and Prostate Cancer: Bias, Precision Medicine, or Population Health?

Konrad H Stopsack1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33551298      PMCID： PMC9552934          DOI： 10.1016/j.eururo.2021.01.008

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   24.267


× No keyword cloud information.
  10 in total

1.  Access and concentrations of atorvastatin in the prostate in men with prostate cancer.

Authors:  Emma Knuuttila; Jarno Riikonen; Heimo Syvälä; Seppo Auriola; Teemu J Murtola
Journal:  Prostate       Date:  2019-06-24       Impact factor: 4.104

2.  Statin drugs and risk of advanced prostate cancer.

Authors:  Elizabeth A Platz; Michael F Leitzmann; Kala Visvanathan; Eric B Rimm; Meir J Stampfer; Walter C Willett; Edward Giovannucci
Journal:  J Natl Cancer Inst       Date:  2006-12-20       Impact factor: 13.506

3.  Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer.

Authors:  Signe Benzon Larsen; Christian Dehlendorff; Charlotte Skriver; Susanne Oksbjerg Dalton; Christina Gade Jespersen; Michael Borre; Klaus Brasso; Mette Nørgaard; Christoffer Johansen; Henrik Toft Sørensen; Jesper Hallas; Søren Friis
Journal:  J Clin Oncol       Date:  2017-08-14       Impact factor: 44.544

4.  Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase.

Authors:  Ajay Gupta; David Thompson; Andrew Whitehouse; Tim Collier; Bjorn Dahlof; Neil Poulter; Rory Collins; Peter Sever
Journal:  Lancet       Date:  2017-05-02       Impact factor: 79.321

5.  Avoidable flaws in observational analyses: an application to statins and cancer.

Authors:  Barbra A Dickerman; Xabier García-Albéniz; Roger W Logan; Spiros Denaxas; Miguel A Hernán
Journal:  Nat Med       Date:  2019-10-07       Impact factor: 53.440

6.  Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer.

Authors:  Lauren C Harshman; Xiaodong Wang; Mari Nakabayashi; Wanling Xie; Loana Valenca; Lillian Werner; Yongjiang Yu; Aaron M Kantoff; Christopher J Sweeney; Lorelei A Mucci; Mark Pomerantz; Gwo-Shu Mary Lee; Philip W Kantoff
Journal:  JAMA Oncol       Date:  2015-07       Impact factor: 31.777

7.  Use of statins and the risk of death in patients with prostate cancer.

Authors:  Oriana Yu; Maria Eberg; Serge Benayoun; Armen Aprikian; Gerald Batist; Samy Suissa; Laurent Azoulay
Journal:  J Clin Oncol       Date:  2013-11-04       Impact factor: 44.544

8.  Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer.

Authors:  Christopher J Sweeney; Stephen P Finn; Lorelei A Mucci; Emma H Allott; Ericka M Ebot; Konrad H Stopsack; Amparo G Gonzalez-Feliciano; Sarah C Markt; Kathryn M Wilson; Thomas U Ahearn; Travis A Gerke; Mary K Downer; Jennifer R Rider; Stephen J Freedland; Tamara L Lotan; Philip W Kantoff; Elizabeth A Platz; Massimo Loda; Meir J Stampfer; Edward Giovannucci
Journal:  Clin Cancer Res       Date:  2019-11-21       Impact factor: 12.531

9.  Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study.

Authors:  Darryl P Leong; Vincent Fradet; Bobby Shayegan; Emmanuelle Duceppe; Robert Siemens; Tamim Niazi; Laurence Klotz; Ian Brown; Joseph Chin; Luke Lavallee; Negareh Mousavi; Patrick Luke; Himu Lukka; Darin Gopaul; Philippe Violette; Rob J Hamilton; Margot K Davis; Sarah Karampatos; Rajibul Mian; Guila Delouya; Yves Fradet; Som Mukherjee; David Conen; Annabel Chen-Tournoux; Christopher Johnson; Amal Bessissow; George Dresser; Adnan Kazi Hameed; Husam Abdel-Qadir; Alp Sener; Raveen Pal; P J Devereaux; Jehonathan Pinthus
Journal:  J Urol       Date:  2020-01-03       Impact factor: 7.450

10.  The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy.

Authors:  Robert J Hamilton; Keyue Ding; Juanita M Crook; Christopher J O'Callaghan; Celestia S Higano; David P Dearnaley; Eric M Horwitz; S Larry Goldenberg; Mary K Gospodarowicz; Laurence Klotz
Journal:  Eur Urol       Date:  2020-12-31       Impact factor: 20.096
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.